| 01/25/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1875.00 |
Details |
| Payment from |
Novartis Pharma AG |
| Payment Record ID |
839376063 |
|
| 06/30/2021 |
Research |
In-kind items and services |
Drug |
$443.78 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU TAPISTRY PHASE II PLATFORM TRIAL |
| Payment Record ID |
835897305 |
|
| 06/30/2021 |
Research |
In-kind items and services |
Drug |
$443.78 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
TUMOR-AGNOSTIC PRECISION IMMUNO-ONCOLOGY AND SOMATIC TARGETING RATIONAL FOR YOU TAPISTRY PHASE II PLATFORM TRIAL |
| Payment Record ID |
835897295 |
|
| 03/31/2021 |
Research |
In-kind items and services |
Drug |
$99.24 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
AN OPEN-LABEL, MULTICENTER, GLOBAL PHASE 2 BASKET STUDY OF ENTRECTINIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS THAT HARBOR NTRK123, ROS1, OR ALK GENE REARRANGEMENTS, A PHASE I DOSE ESCALATION STUDY OF ENTRECTINIB RXDX-101 IN ADULT PATIENTS WITH ADVANCEDMETASTATIC SOLID TUMORS, A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF ORAL ENTRECTINIB RXDX-101 IN ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC CANCER CONFIRMED TO BE POSITIVE FOR NTRK1, NTRK2, NT |
| Payment Record ID |
835897289 |
|
| 03/31/2021 |
Research |
In-kind items and services |
Drug |
$315.89 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
AN OPEN-LABEL, MULTICENTER, GLOBAL PHASE 2 BASKET STUDY OF ENTRECTINIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS THAT HARBOR NTRK123, ROS1, OR ALK GENE REARRANGEMENTS, A PHASE I DOSE ESCALATION STUDY OF ENTRECTINIB RXDX-101 IN ADULT PATIENTS WITH ADVANCEDMETASTATIC SOLID TUMORS, A PHASE 1, MULTICENTER, OPEN-LABEL STUDY OF ORAL ENTRECTINIB RXDX-101 IN ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC CANCER CONFIRMED TO BE POSITIVE FOR NTRK1, NTRK2, NT |
| Payment Record ID |
835897283 |
|
| 03/31/2021 |
Research |
In-kind items and services |
Drug |
$2536.87 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
A PHASE 11B, OPEN-LABEL, DOSE-ESCALATION AND EXPANSION STUDY OF ENTRECTINIB RXDX-101 IN CHILDREN AND ADOLESCENTS WITH RECURRENT OR REFRACTORY SOLID TUMORS AND PRIMARY CNS TUMORS, WITH OR WITHOUT TRK, ROS1, OR ALK FUSIONS, AN OPEN-LABEL, MULTICENTER, GLOBAL PHASE 2 BASKET STUDY OF ENTRECTINIB FOR THE TREATMENT OF PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMORS THAT HARBOR NTRK123, ROS1, OR ALK GENE REARRANGEMENTS, A PHASE I DOSE ESCALATION STUDY OF ENTRECTINIB RXDX-101 IN ADULT P |
| Payment Record ID |
835897277 |
|
| 07/09/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3300.00 |
Details |
| Payment from |
Chugai Pharmaceutical Co., Ltd. |
| Payment Record ID |
835886105 |
|
| 07/23/2021 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$600.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
832876267 |
|
| 11/19/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1947.00 |
Details |
| Payment from |
Amgen Inc. |
| Payment Record ID |
826527271 |
|
| 11/18/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3900.00 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
821979819 |
|
| 10/08/2021 |
Research |
In-kind items and services |
|
$1619.97 |
Details |
| Payment from |
Eli Lilly and Company |
| Paymment Research Study |
LIBRETTO-432: A PLACEBO-CONTROLLED DOUBLE-BLINDED RANDOMIZED PHASE 3 STUDY OF ADJUVANT SELPERCATINIB FOLLOWING DEFINITIVE LOCOREGIONAL TREATMENT IN PARTICIPANTS WITH STAGE IB-IIIA RET FUSION-POSITIVE NSCLC |
| Clinical Trials Gov ID |
NCT04819100 |
| Payment Record ID |
819443447 |
|
| 09/16/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2406.25 |
Details |
| Payment from |
Eli Lilly and Company |
| Payment Record ID |
818931427 |
|
| 06/04/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$437.50 |
Details |
| Payment from |
Eli Lilly and Company |
| Payment Record ID |
818925321 |
|
| 09/10/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$4200.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
789035767 |
|
| 11/02/2021 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1010.00 |
Details |
| Payment from |
Janssen Scientific Affairs, LLC |
| Payment Record ID |
788414125 |
|
| 10/01/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$875.00 |
Details |
| Payment from |
Eli Lilly and Company |
| Payment Record ID |
753917019 |
|
| 07/27/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3000.00 |
Details |
| Payment from |
EMD Serono, Inc. |
| Payment Record ID |
751286703 |
|
| 09/16/2020 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1653.96 |
Details |
| Payment from |
Boehringer Ingelheim Pharma GmbH & Co.KG |
| Payment Record ID |
749444217 |
|
| 08/07/2020 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1041.71 |
Details |
| Payment from |
Boehringer Ingelheim Pharma GmbH & Co.KG |
| Payment Record ID |
749444205 |
|
| 12/14/2020 |
General (Non-Research) |
Cash or cash equivalent |
Honoraria |
$2000.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
743804209 |
|
| 09/14/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$990.00 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
742976447 |
|
| 06/04/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1815.00 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
742976441 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$137.15 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements |
| Payment Record ID |
742972123 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$341.49 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
A Phase 11b, Open-Label, Dose-Escalation and Expansion Study of Entrectinib RXDX-101 in Children and Adolescents with Recurrent or Refractory Solid Tumors and Primary CNS Tumors, with or without TRK, ROS1, or ALK Fusions, An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult |
| Payment Record ID |
742972109 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$122.72 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972101 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$122.72 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
A Phase 11b, Open-Label, Dose-Escalation and Expansion Study of Entrectinib RXDX-101 in Children and Adolescents with Recurrent or Refractory Solid Tumors and Primary CNS Tumors, with or without TRK, ROS1, or ALK Fusions, An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult |
| Payment Record ID |
742972091 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$129.53 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972079 |
|
| 06/30/2020 |
Research |
In-kind items and services |
Biological |
$448.56 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972069 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$178.58 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972061 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$178.58 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements |
| Payment Record ID |
742972051 |
|
| 09/30/2020 |
Research |
In-kind items and services |
Biological |
$178.58 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972041 |
|
| 03/31/2020 |
Research |
In-kind items and services |
Biological |
$181.55 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972037 |
|
| 03/31/2020 |
Research |
In-kind items and services |
Biological |
$396.85 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
An Open-Label, Multicenter, Global Phase 2 Basket Study of Entrectinib for the Treatment of Patients with Locally Advanced or Metastatic Solid Tumors that Harbor NTRK123, ROS1, or ALK Gene Rearrangements, A Phase I Dose Escalation Study of Entrectinib RXDX-101 in Adult patients with AdvancedMetastatic Solid Tumors, A Phase 1, Multicenter, Open-Label Study of Oral Entrectinib RXDX-101 in Adult Patients with Locally Advanced or Metastatic Cancer Confirmed to be Positive for NTRK1, NTRK2 |
| Payment Record ID |
742972027 |
|
| 12/31/2020 |
Research |
In-kind items and services |
Biological |
$747.45 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
STARTRK 2 RXDX 101 02 |
| Payment Record ID |
742972015 |
|
| 12/31/2020 |
Research |
In-kind items and services |
Biological |
$99.96 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
STARTRK 2 RXDX 101 02, ALKA ALKA 372 001 and STARTRK 1 RXDX 101 01 |
| Payment Record ID |
742972007 |
|
| 12/31/2020 |
Research |
In-kind items and services |
Biological |
$1631.85 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
Open Label Dose Escalation and Expansion Study of Entrectinib RXDX 101 in Children, STARTRK 2 RXDX 101 02, ALKA ALKA 372 001 and STARTRK 1 RXDX 101 01 |
| Payment Record ID |
742971999 |
|
| 12/31/2020 |
Research |
In-kind items and services |
Biological |
$2589.00 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Paymment Research Study |
STARTRK 2 RXDX 101 02 |
| Payment Record ID |
742971987 |
|
| 07/03/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2000.00 |
Details |
| Payment from |
AstraZeneca UK Limited |
| Payment Record ID |
736390383 |
|
| 12/01/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$875.00 |
Details |
| Payment from |
Eli Lilly and Company |
| Payment Record ID |
728340595 |
|
| 09/01/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2187.50 |
Details |
| Payment from |
Lilly USA, LLC |
| Payment Record ID |
728321803 |
|
| 07/15/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3850.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
713648161 |
|
| 10/14/2020 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2100.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
713628183 |
|
| 09/18/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$161.94 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703448337 |
|
| 10/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$369.84 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703446427 |
|
| 09/27/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$143.95 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703446425 |
|
| 09/18/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$729.44 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703446423 |
|
| 09/24/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$468.47 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703446419 |
|
| 07/17/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$564.94 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703446417 |
|
| 07/18/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$91.56 |
Details |
| Payment from |
Boehringer Ingelheim International GmbH |
| Payment Record ID |
703446199 |
|
| 09/04/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1040.00 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
681372615 |
|
| 02/20/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$447.87 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
681335061 |
|
| 02/20/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3100.00 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
681323027 |
|
| 02/20/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$198.87 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
681289023 |
|
| 02/20/2019 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$358.20 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
681149253 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$302.50 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681078951 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$457.25 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681078545 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$350.95 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681077923 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$424.74 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681077583 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$218.47 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681076841 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$354.44 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681076807 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1124.63 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681076665 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$259.65 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681076325 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1295.26 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681075717 |
|
| 06/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$250.81 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681074105 |
|
| 03/31/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$192.96 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681073520 |
|
| 03/31/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$189.80 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681073405 |
|
| 03/31/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$158.23 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681072929 |
|
| 06/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$260.67 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681072377 |
|
| 06/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$497.61 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681071899 |
|
| 06/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$563.58 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
681071167 |
|
| 09/06/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2000.00 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
675776945 |
|
| 09/06/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$27.50 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
675776943 |
|
| 09/06/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$309.40 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
675776941 |
|
| 09/06/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$4586.86 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
675776939 |
|
| 07/01/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1400.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
673791541 |
|
| 01/30/2019 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$3200.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
672679365 |
|
| 09/30/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$35.55 |
Details |
| Payment from |
Eli Lilly and Company |
| Payment Record ID |
657662185 |
|
| 09/08/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$6.03 |
Details |
| Payment from |
Eli Lilly and Company |
| Payment Record ID |
657660911 |
|
| 04/14/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$938.68 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628486229 |
|
| 03/15/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$19.56 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628479649 |
|
| 01/08/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2100.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628474639 |
|
| 03/19/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$33.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628474425 |
|
| 01/28/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$6300.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628470413 |
|
| 03/15/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$57.12 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628468075 |
|
| 03/15/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$20.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628464401 |
|
| 04/26/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$18.17 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628463975 |
|
| 03/15/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$33.67 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628461341 |
|
| 04/11/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$59.65 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628461175 |
|
| 03/19/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$67.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628460385 |
|
| 11/06/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2695.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628458773 |
|
| 06/28/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$5600.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628455403 |
|
| 06/05/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$5600.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628453257 |
|
| 02/05/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$6030.03 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628449229 |
|
| 03/15/2019 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$63.60 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628446921 |
|
| 03/19/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$11.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628442587 |
|
| 04/26/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$7000.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628422011 |
|
| 09/28/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$40.80 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628419513 |
|
| 03/15/2019 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3150.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628417859 |
|
| 03/15/2019 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$90.62 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
628416319 |
|
| 06/14/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$6790.00 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102405 |
|
| 05/17/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$285.60 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102401 |
|
| 04/18/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$45.23 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102395 |
|
| 04/18/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$19.91 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102389 |
|
| 04/18/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$44.82 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102385 |
|
| 04/18/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$221.89 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102377 |
|
| 04/18/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$25.15 |
Details |
| Payment from |
Helsinn Healthcare SA |
| Payment Record ID |
611102369 |
|
| 09/26/2018 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$940.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610437725 |
|
| 05/04/2018 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$330.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
610437721 |
|
| 09/22/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$44.97 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
602640785 |
|
| 09/22/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3300.00 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
602636155 |
|
| 09/30/2018 |
General (Non-Research) |
In-kind items and services |
Consulting Fee |
$254.07 |
Details |
| Payment from |
F. Hoffmann-La Roche AG |
| Payment Record ID |
602629453 |
|
| 02/16/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$166.78 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Payment Record ID |
593033651 |
|
| 02/16/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$281.37 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Payment Record ID |
593021461 |
|
| 02/16/2018 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$41.56 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Payment Record ID |
593021447 |
|
| 02/16/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$4200.00 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Payment Record ID |
593021151 |
|
| 02/16/2018 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$451.60 |
Details |
| Payment from |
Takeda Pharmaceuticals U.S.A., Inc. |
| Payment Record ID |
593020875 |
|
| 07/25/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$10.98 |
Details |
| Payment from |
Foundation Medicine, Inc. |
| Payment Record ID |
585908595 |
|
| 07/25/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$25.94 |
Details |
| Payment from |
Foundation Medicine, Inc. |
| Payment Record ID |
585908587 |
|
| 10/04/2018 |
General (Non-Research) |
Cash or cash equivalent |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1980.00 |
Details |
| Payment from |
Exelixis Inc. |
| Payment Record ID |
566890933 |
|
| 09/14/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$74.89 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
537175123 |
|
| 10/04/2018 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2100.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
537175111 |
|
| 05/31/2018 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$125.00 |
Details |
| Payment from |
Bayer HealthCare Pharmaceuticals Inc. |
| Payment Record ID |
537174943 |
|
| 10/13/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3800.00 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
513173339 |
|
| 10/13/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$429.01 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
513172933 |
|
| 10/14/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$147.41 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
513172169 |
|
| 10/13/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$285.73 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
513171769 |
|
| 08/04/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1859.88 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506450389 |
|
| 10/18/2017 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$670.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
506450379 |
|
| 11/03/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$204.15 |
Details |
| Payment from |
Millennium Pharmaceuticals, Inc. |
| Payment Record ID |
492612419 |
|
| 11/03/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$202.67 |
Details |
| Payment from |
Millennium Pharmaceuticals, Inc. |
| Payment Record ID |
492598327 |
|
| 11/03/2017 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$40.37 |
Details |
| Payment from |
Millennium Pharmaceuticals, Inc. |
| Payment Record ID |
492594757 |
|
| 11/03/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$8700.00 |
Details |
| Payment from |
Millennium Pharmaceuticals, Inc. |
| Payment Record ID |
492594755 |
|
| 11/03/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$332.40 |
Details |
| Payment from |
Millennium Pharmaceuticals, Inc. |
| Payment Record ID |
492594753 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$53.39 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445933157 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$274.25 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445784707 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$62.95 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445712351 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$13.23 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445519675 |
|
| 06/28/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1860.00 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445151205 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$33.15 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445067045 |
|
| 10/08/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$4650.00 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445050507 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$271.44 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445045307 |
|
| 09/28/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$274.25 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
445033845 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$167.88 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444869257 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$27.00 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444864745 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$46.31 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444857251 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$17.64 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444856711 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$33.68 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444856431 |
|
| 05/07/2017 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$5600.00 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444851137 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$16.84 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444828575 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$245.37 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444813517 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$119.80 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444812359 |
|
| 01/20/2017 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$365.86 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
444789747 |
|
| 09/08/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$110.00 |
Details |
| Payment from |
ARIAD Pharmaceuticals, Inc. |
| Payment Record ID |
419839417 |
|
| 09/30/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$46.00 |
Details |
| Payment from |
ARIAD Pharmaceuticals, Inc. |
| Payment Record ID |
419839309 |
|
| 09/30/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$3500.00 |
Details |
| Payment from |
ARIAD Pharmaceuticals, Inc. |
| Payment Record ID |
419839289 |
|
| 06/07/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$207.09 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
412327122 |
|
| 06/06/2016 |
General (Non-Research) |
Cash or cash equivalent |
Food and Beverage |
$21.19 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
412325028 |
|
| 06/06/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2200.00 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
412078024 |
|
| 06/06/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$279.00 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
412062184 |
|
| 06/06/2016 |
General (Non-Research) |
Cash or cash equivalent |
Travel and Lodging |
$313.46 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
412062182 |
|
| 06/06/2016 |
General (Non-Research) |
In-kind items and services |
Travel and Lodging |
$196.93 |
Details |
| Payment from |
Genentech USA, Inc. |
| Payment Record ID |
412062177 |
|
| 07/18/2016 |
General (Non-Research) |
In-kind items and services |
Food and Beverage |
$23.75 |
Details |
| Payment from |
Merck Sharp & Dohme Corporation |
| Payment Record ID |
406105784 |
|
| 02/02/2016 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$340.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
405198466 |
|
| 08/09/2016 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$1900.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
404698060 |
|
| 06/07/2016 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$970.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
404592254 |
|
| 12/07/2016 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$970.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
404565266 |
|
| 07/15/2016 |
General (Non-Research) |
In-kind items and services |
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program |
$340.00 |
Details |
| Payment from |
Pfizer Inc. |
| Payment Record ID |
404521026 |
|
| 08/08/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$1313.00 |
Details |
| Payment from |
PFIZER INC. |
| Payment Record ID |
403592608 |
|
| 07/25/2016 |
General (Non-Research) |
Cash or cash equivalent |
Consulting Fee |
$2325.00 |
Details |
| Payment from |
AstraZeneca Pharmaceuticals LP |
| Payment Record ID |
362486222 |
|
